Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. ca.finance.yahoo.com › quote › EIGREiger BioPharmaceuticals, Inc. (EIGR) Latest Stock News &...

   ca.finance.yahoo.com › quote › EIGR

   • Αποθηκευμένο αντίγραφο

   Get the latest Eiger BioPharmaceuticals, Inc. (EIGR) stock news and headlines to help you in your trading and investing decisions.

2. www.forbes.com › companies › eiger-biopharmaceuticalsEIGR Stock Price, Company Overview & News - Forbes

   www.forbes.com › companies › eiger-biopharmaceuticals

   • Αποθηκευμένο αντίγραφο

   23 Οκτ 2024 · American star Coco Gauff defeated world No. 2 Iga Swiatek 6-3, 6-4 on Tuesday, sealing her spot in the semifinals of the year-end WTA Finals in Riyadh, Saudi Arabia. Trump has defeated Harris ...

3. finance.yahoo.com › news › eiger-biopharmaceuticals-eigr-reports-q3-222510533Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue...

   finance.yahoo.com › news › eiger-biopharmaceuticals-eigr-reports-q3-222510533

   • Αποθηκευμένο αντίγραφο

   4 Νοε 2021 · Eiger BioPharma (EIGR) delivered earnings and revenue surprises of -12.07% and 19.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...

4. www.marketscreener.com › quote › stockEiger BioPharmaceuticals Stock (EIGR) - Quote OTC Markets-...

   www.marketscreener.com › quote › stock

   • Αποθηκευμένο αντίγραφο

   27 Σεπ 2024 · Eiger InnoTherapeutics, Inc. completed the acquisition of Lonafarnib Antiviral Asset of Eiger BioPharmaceuticals, Inc. from Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $5.2 million. Sep. 02 CI

5. au.finance.yahoo.com › quote › EIGREiger BioPharmaceuticals, Inc. (EIGR) stock price, news, quote...

   au.finance.yahoo.com › quote › EIGR

   Find the latest Eiger BioPharmaceuticals, Inc. (EIGR) stock quote, history, news and other vital information to help you with your stock trading and investing.

6. stocknews.com › stock › EIGREIGR News: Earnings, Analyst Moves, and More - StockNews

   stocknews.com › stock › EIGR

   • Αποθηκευμένο αντίγραφο

   Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases, today reported financial results for the third quarter 2023 and provided a business update.

7. www.fool.com › quote › nasdaqEiger BioPharmaceuticals - EIGR - Stock Price & News | The Motley...

   www.fool.com › quote › nasdaq

   • Αποθηκευμένο αντίγραφο

   Real time Eiger BioPharmaceuticals (EIGR) stock price quote, stock graph, news & analysis.